Revenue

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.

As SIGA prepares to unveil its 2025 financials, investors are focused on the future of its Tpoxx contracts and its role in global biodefense strategy.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

The deal sees CPM and MW Components move to UK-based Rosebank Industries, marking a major exit for the private equity firm and a strategic US expansion.

Former Novo Nordisk CSO Marcus Schindler joins Cradle, validating AI's role in accelerating drug discovery and reshaping traditional pharmaceutical R&D.

A new multi-year deal with XCharge will bring 400kW ultra-fast chargers to EnBW's network, aiming for enhanced reliability and European-made hardware.

In its first year post-Comcast, Versant Media battles linear TV declines with a bold digital pivot, a new dividend, and a $1 billion stock buyback.

A significant order for critical Tomahawk missile parts sends Mobix Labs' stock soaring, highlighting the firm's key role in a surging defense market.

How a strategic tech partnership manages thousands of fans for PBS's top show, revealing the complex logistics behind free, high-demand cultural events.

After a kidney trial setback, CalciMedica's lead drug Auxora shows strong promise for acute pancreatitis, but a tight cash runway looms over its future.

A new partnership turns existing conference rooms into high-quality TV studios, aiming to boost ROI, culture, and the quality of corporate events.

Amid a booming gene therapy market, Oxford Biomedica Solutions launches key investor events to showcase its strategy and secure its leadership position.

Facing declining revenue, Goodfood adds restructuring and digital experts to its board. Can this shake-up revive the Canadian meal-kit pioneer?

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

Axxess's upcoming conference tackles AI's role in home health, unveils a new leadership certification, and honors an industry titan. Here's what it means.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

The private equity firm's carve-out of the world's largest coworking franchisor signals a major push to scale flexible workspaces for the hybrid era.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

Indian EdTech firm EasyShiksha appoints Deepti Barman to lead strategic alliances, signaling a major push to compete on the global stage.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.